BMY — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates BMY as Bearish with 72% confidence in the Healthcare sector.
AI Analysis Summary
BMY presents significant financial risks and overvaluation despite strong fundamentals, warranting a bearish stance.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade C — 45/100
- Bill Ackman (Activist Investing): Grade C — 55/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Bearish
Price Intelligence
- Current price: $58.27
- Price target: $57.20 (-1.8%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: intangible assets
Peer Group Analysis
BMY is in the “Strong Cash Flow” cluster alongside WSM, WY, WTW, WMT, WELL (127 stocks total). 2 of 127 peers are currently bullish.